221 related articles for article (PubMed ID: 27506743)
1. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI).
Kurko J; Tringham M; Tanner L; Näntö-Salonen K; Vähä-Mäkilä M; Nygren H; Pöhö P; Lietzen N; Mattila I; Olkku A; Hyötyläinen T; Orešič M; Simell O; Niinikoski H; Mykkänen J
Metabolism; 2016 Sep; 65(9):1361-75. PubMed ID: 27506743
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI).
Mykkänen J; Torrents D; Pineda M; Camps M; Yoldi ME; Horelli-Kuitunen N; Huoponen K; Heinonen M; Oksanen J; Simell O; Savontaus ML; Zorzano A; Palacín M; Aula P
Hum Mol Genet; 2000 Feb; 9(3):431-8. PubMed ID: 10655553
[TBL] [Abstract][Full Text] [Related]
3. Long-term oral lysine supplementation in lysinuric protein intolerance.
Tanner LM; Näntö-Salonen K; Niinikoski H; Huoponen K; Simell O
Metabolism; 2007 Feb; 56(2):185-9. PubMed ID: 17224331
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport.
Kurko J; Vähä-Mäkilä M; Tringham M; Tanner L; Paavanen-Huhtala S; Saarinen M; Näntö-Salonen K; Simell O; Niinikoski H; Mykkänen J
Mol Immunol; 2015 Oct; 67(2 Pt B):416-25. PubMed ID: 26210182
[TBL] [Abstract][Full Text] [Related]
5. Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood.
Mauhin W; Habarou F; Gobin S; Servais A; Brassier A; Grisel C; Roda C; Pinto G; Moshous D; Ghalim F; Krug P; Deltour N; Pontoizeau C; Dubois S; Assoun M; Galmiche L; Bonnefont JP; Ottolenghi C; de Blic J; Arnoux JB; de Lonlay P
Orphanet J Rare Dis; 2017 Jan; 12(1):3. PubMed ID: 28057010
[TBL] [Abstract][Full Text] [Related]
6. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
[TBL] [Abstract][Full Text] [Related]
7. Combined hyperlipidemia in patients with lysinuric protein intolerance.
Tanner LM; Niinikoski H; Näntö-Salonen K; Simell O
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S145-50. PubMed ID: 20177788
[TBL] [Abstract][Full Text] [Related]
8. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance.
Borsani G; Bassi MT; Sperandeo MP; De Grandi A; Buoninconti A; Riboni M; Manzoni M; Incerti B; Pepe A; Andria G; Ballabio A; Sebastio G
Nat Genet; 1999 Mar; 21(3):297-301. PubMed ID: 10080183
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic features of lysinuric protein intolerance in Japan.
Noguchi A; Nakamura K; Murayama K; Yamamoto S; Komatsu H; Kizu R; Takayanagi M; Okuyama T; Endo F; Takasago Y; Shoji Y; Takahashi T
Pediatr Int; 2016 Oct; 58(10):979-983. PubMed ID: 26865117
[TBL] [Abstract][Full Text] [Related]
10. Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance.
Barilli A; Rotoli BM; Visigalli R; Bussolati O; Gazzola GC; Gatti R; Dionisi-Vici C; Martinelli D; Goffredo BM; Font-Llitjós M; Mariani F; Luisetti M; Dall'Asta V
Mol Genet Metab; 2012 Apr; 105(4):585-9. PubMed ID: 22325938
[TBL] [Abstract][Full Text] [Related]
11. Exploring the transcriptomic variation caused by the Finnish founder mutation of lysinuric protein intolerance (LPI).
Tringham M; Kurko J; Tanner L; Tuikkala J; Nevalainen OS; Niinikoski H; Näntö-Salonen K; Hietala M; Simell O; Mykkänen J
Mol Genet Metab; 2012 Mar; 105(3):408-15. PubMed ID: 22221392
[TBL] [Abstract][Full Text] [Related]
12. Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.
Lauteala T; Sistonen P; Savontaus ML; Mykkänen J; Simell J; Lukkarinen M; Simell O; Aula P
Am J Hum Genet; 1997 Jun; 60(6):1479-86. PubMed ID: 9199570
[TBL] [Abstract][Full Text] [Related]
13. Lysinuric protein intolerance: reviewing concepts on a multisystem disease.
Sebastio G; Sperandeo MP; Andria G
Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):54-62. PubMed ID: 21308987
[TBL] [Abstract][Full Text] [Related]
14. Effect of lysine infusion on urea cycle in lysinuric protein intolerance.
Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O
Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173
[TBL] [Abstract][Full Text] [Related]
15. Inducible
Bodoy S; Sotillo F; Espino-Guarch M; Sperandeo MP; Ormazabal A; Zorzano A; Sebastio G; Artuch R; Palacín M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653080
[TBL] [Abstract][Full Text] [Related]
16. Increased NO production in lysinuric protein intolerance.
Mannucci L; Emma F; Markert M; Bachmann C; Boulat O; Carrozzo R; Rizzoni G; Dionisi-Vici C
J Inherit Metab Dis; 2005; 28(2):123-9. PubMed ID: 15877200
[TBL] [Abstract][Full Text] [Related]
17. Genetic homogeneity of lysinuric protein intolerance.
Lauteala T; Mykkänen J; Sperandeo MP; Gasparini P; Savontaus ML; Simell O; Andria G; Sebastio G; Aula P
Eur J Hum Genet; 1998; 6(6):612-5. PubMed ID: 9887380
[TBL] [Abstract][Full Text] [Related]
18. Nutrient intake in lysinuric protein intolerance.
Tanner LM; Näntö-Salonen K; Venetoklis J; Kotilainen S; Niinikoski H; Huoponen K; Simell O
J Inherit Metab Dis; 2007 Oct; 30(5):716-21. PubMed ID: 17588131
[TBL] [Abstract][Full Text] [Related]
19. y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.
Rotoli BM; Barilli A; Visigalli R; Ferrari F; Dall'Asta V
J Cell Mol Med; 2020 Jan; 24(1):921-929. PubMed ID: 31705628
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone deficiency in a patient with lysinuric protein intolerance.
Esposito V; Lettiero T; Fecarotta S; Sebastio G; Parenti G; Salerno M
Eur J Pediatr; 2006 Nov; 165(11):763-6. PubMed ID: 16775724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
